IAMA-005

N/A

Report date: 2024/07/17 09:41:12

Base Information

Drug NameIAMA-005
Drug Alias NameIAMA-005
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 replacementsInterferon alpha replacements
TargetsInterleukin-2Interferon alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Jsiama Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Jsiama Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A